BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22875246)

  • 1. Rapamycin inhibits both motility through down-regulation of p-STAT3 (S727) by disrupting the mTORC2 assembly and peritoneal dissemination in sarcomatoid cholangiocarcinoma.
    Hong SM; Park CW; Cha HJ; Kwon JH; Yun YS; Lee NG; Kim DG; Nam HG; Choi KY
    Clin Exp Metastasis; 2013 Feb; 30(2):177-87. PubMed ID: 22875246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.
    Ewald F; Grabinski N; Grottke A; Windhorst S; Nörz D; Carstensen L; Staufer K; Hofmann BT; Diehl F; David K; Schumacher U; Nashan B; Jücker M
    Int J Cancer; 2013 Nov; 133(9):2065-76. PubMed ID: 23588885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic stellate cells accelerate the malignant behavior of cholangiocarcinoma cells.
    Okabe H; Beppu T; Hayashi H; Ishiko T; Masuda T; Otao R; Horlad H; Jono H; Ueda M; Shinriki S; Ando Y; Baba H
    Ann Surg Oncol; 2011 Apr; 18(4):1175-84. PubMed ID: 21042948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scabraside D Derived from Sea Cucumber Induces Apoptosis and Inhibits Metastasis via iNOS and STAT-3 Expression in Human Cholangiocarcinoma Xenografts.
    Assawasuparerk K; Rawangchue T; Phonarknguen R
    Asian Pac J Cancer Prev; 2016; 17(4):2151-7. PubMed ID: 27221911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capsaicin suppresses the migration of cholangiocarcinoma cells by down-regulating matrix metalloproteinase-9 expression via the AMPK-NF-κB signaling pathway.
    Lee GR; Jang SH; Kim CJ; Kim AR; Yoon DJ; Park NH; Han IS
    Clin Exp Metastasis; 2014 Dec; 31(8):897-907. PubMed ID: 25217963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scabraside D Extracted from Holothuria scabra Induces Apoptosis and Inhibits Growth of Human Cholangiocarcinoma Xenografts in Mice.
    Assawasuparerk K; Vanichviriyakit R; Chotwiwatthanakun C; Nobsathian S; Rawangchue T; Wittayachumnankul B
    Asian Pac J Cancer Prev; 2016; 17(2):511-7. PubMed ID: 26925636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma.
    Chen MH; Chiang KC; Cheng CT; Huang SC; Chen YY; Chen TW; Yeh TS; Jan YY; Wang HM; Weng JJ; Chang PM; Liu CY; Li CP; Chao Y; Chen MH; Huang CY; Yeh CN
    Oncotarget; 2014 May; 5(9):2372-89. PubMed ID: 24796583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic antitumor activity of the combination of salubrinal and rapamycin against human cholangiocarcinoma cells.
    Zhao X; Zhang C; Zhou H; Xiao B; Cheng Y; Wang J; Yao F; Duan C; Chen R; Liu Y; Feng C; Li H; Li J; Dai R
    Oncotarget; 2016 Dec; 7(51):85492-85501. PubMed ID: 27863431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling.
    Lu Z; Wang J; Zheng T; Liang Y; Yin D; Song R; Pei T; Pan S; Jiang H; Liu L
    BMC Cancer; 2014 Oct; 14():783. PubMed ID: 25344679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of 14-3-3 binding to Rictor of mTORC2 for Akt phosphorylation at Ser473 is regulated by selenoprotein W.
    Jeon YH; Park YH; Kwon JH; Lee JH; Kim IY
    Biochim Biophys Acta; 2013 Oct; 1833(10):2135-42. PubMed ID: 23680186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diethyldithiocarbamate suppresses an NF-kappaB dependent metastatic pathway in cholangiocarcinoma cells.
    Srikoon P; Kariya R; Kudo E; Goto H; Vaeteewoottacharn K; Taura M; Wongkham S; Okada S
    Asian Pac J Cancer Prev; 2013; 14(7):4441-6. PubMed ID: 23992017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells.
    Aneknan P; Kukongviriyapan V; Prawan A; Kongpetch S; Sripa B; Senggunprai L
    Asian Pac J Cancer Prev; 2014; 15(12):5071-6. PubMed ID: 24998588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNS-032 inhibits mTORC1/mTORC2 activity in acute myeloid leukemia cells and has synergistic activity with perifosine against Akt.
    Meng H; Jin Y; Liu H; You L; Yang C; Yang X; Qian W
    J Hematol Oncol; 2013 Feb; 6():18. PubMed ID: 23415012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atractylodin inhibited the migration and induced autophagy in cholangiocarcinoma cells via PI3K/AKT/mTOR and p38MAPK signalling pathways.
    Acharya B; Chaijaroenkul W; Na-Bangchang K
    J Pharm Pharmacol; 2021 Aug; 73(9):1191-1200. PubMed ID: 33885818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of ECM1 contributes to migration and invasion in cholangiocarcinoma cell.
    Xiong GP; Zhang JX; Gu SP; Wu YB; Liu JF
    Neoplasma; 2012; 59(4):409-15. PubMed ID: 22489696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling.
    Frampton G; Coufal M; Li H; Ramirez J; DeMorrow S
    Exp Cell Res; 2010 May; 316(9):1465-78. PubMed ID: 20347808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility.
    Gulati N; Karsy M; Albert L; Murali R; Jhanwar-Uniyal M
    Int J Oncol; 2009 Oct; 35(4):731-40. PubMed ID: 19724909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies.
    Gupta M; Hendrickson AE; Yun SS; Han JJ; Schneider PA; Koh BD; Stenson MJ; Wellik LE; Shing JC; Peterson KL; Flatten KS; Hess AD; Smith BD; Karp JE; Barr S; Witzig TE; Kaufmann SH
    Blood; 2012 Jan; 119(2):476-87. PubMed ID: 22080480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of suppresser of cytokine signaling 3 inhibits the IL-6-induced epithelial-to-mesenchymal transition and cholangiocarcinoma cell metastasis.
    Zhou QX; Jiang XM; Wang ZD; Li CL; Cui YF
    Med Oncol; 2015 Apr; 32(4):105. PubMed ID: 25744243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.